Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05723991
Status:
RECRUITING
Last Update Posted:
2023-02-13
First Post:
2023-02-01
Brief Title:
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma
Sponsor:
Chunguang yang 101937
Organization:
Tongji Hospital
Organization Data
Organization:
Tongji Hospital
Class:
OTHER
Study ID:
222 LSZ S137 No
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chunguang yang 101937
Lead Sponsor Class:
OTHER
Responsible Party:
Chunguang yang 101937
Responsible Party Title:
Professor
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Tongji Hospital
Old Name:
None
Old Organization:
None